Malaria

Collective intelligence needed to solve malaria

Collective intelligence needed to solve malaria. Hear Leann Tilley explain

Bio21 Big Picture Seminar: Alternative Drug Discovery in Pharma...a snapshot of diversity in GSK drug discovery through collaboration

Friday, 26 August, 2016 - 13:15

Hear John Haselden, VP and Head of Malaria Discovery GSK speak about examples from GSK’s 'alternative' portfolio, including Diseases of the Developing World and Maternal/Neonatal Health.

Biochemistry and Molecular Biology Seminar Series presents Stephen Batinovic, PhD Oration

Wednesday, 6 April, 2016 - 12:00 to 13:00

“A network of protein interactions required for trafficking of PfEMP1 in P. falciparum infected erythrocytes” 

Biochemistry and Molecular Biology Seminar Series presents A/Prof Fasseli Coulibaly, Monash University

Wednesday, 23 March, 2016 - 12:00 to 13:00

"In vivo crystals of viruses: a challenge for structural biology, an opportunity for new vaccines" presented by Associate Professor Fasseli CoulibalyMonash University, Structural Virology Laboratory.

Biochemistry and Molecular Biology Seminar Series presents Dr Wai-Hong Tam, WEHI

Wednesday, 16 March, 2016 - 12:00 to 13:00

"Malaria Parasite Invasion: versatile structural scaffolds and alternate erythrocyte receptors"

Media Release: New hope in global race to beat malaria parasite’s deadly new resistance

Scientists have made a major breakthrough in the global search for a new drug to beat the malaria parasite’s growing resistance to first-defence treatments.

Academia and industry join forces against malaria

Professor Leann Tilley and Stanley Cheng Xie from the Bio21 Institute are joining with Takeda Pharmaceuticals in the fight against malarial drug resistance.

PhD Oration by Charisse Pasaje, 'Protein translation as a drug target in malaria'

Wednesday, 18 November, 2015 - 12:00 to 13:00

Charisse Pasaje is a student from the Ralph Laboratory at the Bio21 Institute, the University of Melbourne.

 

Ten Years Big Picture Seminar - "Measuring and modelling malaria parasites: Why Bio21 is a great place to do convergence science"

Thursday, 10 September, 2015 - 16:00 to 17:00

Professor Leann Tilley will discuss her aims in malaria research and reflect more broadly on how the Bio21 Molecular Science and Biotechnology Institute is an ideal environment to undertake convergence science.

Subscribe to RSS - Malaria